Home » Topics » BioWorld Science, Cardiovascular

BioWorld Science, Cardiovascular
RSS

Perindopril accelerates endothelial regrowth in animal model

April 7, 1997

Targeted Genetics' AAV vector useful for in vivo cardiovascular gene therapy

April 4, 1997

Mitsubishi Chemical isolates antihypertensive compound from natural source

April 4, 1997

Digital Gene Technologies and Recordati collaborate on atherosclerosis research

April 4, 1997

Roberts licenses cardiovascular drug from Pfizer

April 3, 1997

Cardioprotective and cerebroprotective agents from Pierre Fabre

April 3, 1997

More endothelin antagonists from SKB

April 3, 1997

NeoRx licenses Biostent to Schwarz

April 3, 1997

Amylin acquires rights to cardiovascular agents from Hoechst Marion Roussel

April 2, 1997

Vasopressin antagonists from JT

April 2, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...